Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINHALATIONGeneric

PENTHRANE

METHOXYFLURANE

Standard Dose
99.9%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview PENTHRANE is listed in Drugs@FDA under application 013056 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient METHOXYFLURANE Form and strength LIQUID; INHALATION - 99.9% Sponsor ABBOTT Submission history Latest submission status date: 2001-09-17 00:00:00.

Structured Monograph

Clinical summary

Approval overview PENTHRANE is listed in Drugs@FDA under application 013056 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient METHOXYFLURANE Form and strength LIQUID; INHALATION - 99.9% Sponsor ABBOTT Submission history Latest submission status date: 2001-09-17 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.